Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APTO

Aptose Biosciences (APTO) Stock Price, News & Analysis

Aptose Biosciences logo

About Aptose Biosciences Stock (NASDAQ:APTO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.71
$6.86
52-Week Range
N/A
Volume
650,294 shs
Average Volume
227,964 shs
Market Capitalization
$3.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Strong Buy

Company Overview

Aptose Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

APTO MarketRank™: 

Aptose Biosciences scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aptose Biosciences has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Aptose Biosciences has received no research coverage in the past 90 days.

  • Read more about Aptose Biosciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aptose Biosciences is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aptose Biosciences is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for APTO.
  • Dividend Yield

    Aptose Biosciences does not currently pay a dividend.

  • Dividend Growth

    Aptose Biosciences does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for APTO.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Aptose Biosciences this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Aptose Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.33% of the stock of Aptose Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 26.62% of the stock of Aptose Biosciences is held by institutions.

  • Read more about Aptose Biosciences' insider trading history.
Receive APTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APTO Stock News Headlines

Aptose Biosciences Inc News (APS) - Investing.com
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
See More Headlines

APTO Stock Analysis - Frequently Asked Questions

Aptose Biosciences Inc. (NASDAQ:APTO) announced its quarterly earnings data on Thursday, August, 8th. The biotechnology company reported ($12.90) EPS for the quarter, beating the consensus estimate of ($17.40) by $4.50.

Aptose Biosciences shares reverse split on Wednesday, February 26th 2025.The 1-30 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 25th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aptose Biosciences investors own include Digital Turbine (APPS), Okta (OKTA), Canoo (GOEV), CrowdStrike (CRWD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/08/2024
Today
8/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:APTO
CIK
882361
Employees
31
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($89.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$51.21 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-5,683.22%
Return on Assets
-300.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.05
Quick Ratio
1.05

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.19) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,141,000
Free Float
63,446,000
Market Cap
$3.66 million
Optionable
No Data
Beta
1.04

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:APTO) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners